|
1
|
Ziegler RG, Anderson WF and Mh G:
Increasing breast cancer incidence in China: the numbers add up.
JNCI. 100:1339–1341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Linos E, Rosner BA and Linos K: Effects of
reproductive and demographic changes on breast cancer incidence in
China: a modeling analysis. JNCI. 100:1352–1359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Massague J and Chen YG: Controlling
TGF-beta signaling. Genes Dev. 14:627–644. 2000.
|
|
4
|
Gobbi H, Arteaga CL, Jensen RA, Simpson
JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD Jr and Page DL:
Loss of expression of transforming growth factor beta type II
receptor correlates with high tumour grade in human breast in situ
and invasive carcinomas. Histopathology. 36:168–177. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gobbi H, Dupont WD, Simpson JF, Plummer WD
Jr, Schuyler PA, Olson SJ, Arteaga CL and Page DL: Transforming
growth factor-beta and breast cancer risk in women with mammary
epithelial hyperplasia. J Natl Cancer Inst. 91:2096–2101. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Daniel CW and Robinson SD: Regulation of
mammary growth and function by TGF-beta. Mol Reprod Dev.
32:145–151. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barcellos-Hoff MH and Ewan KB:
Transforming growth factor-beta and breast cancer: mammary gland
development. Breast Cancer Res. 2:92–99. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
White RL: Tumor suppressing pathways.
Cell. 92:591–592. 1998. View Article : Google Scholar
|
|
9
|
Cambien F, Ricard S, Troesch A, Mallet C,
Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB and Poirier
O: Polymorphisms of the transforming growth factor-beta 1 gene in
relation to myocardial infarction and blood pressure. The Etude
Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension.
28:881–887. 1996.PubMed/NCBI
|
|
10
|
Seijo ER, Song H, Lynch MA, Jennings R,
Qong X, Lazaridis E, Muro-Cacho C, Weghorst CM and Munoz-Antonia T:
Identification of genetic alterations in the TGFbeta type II
receptor gene promoter. Mutat Res. 483:19–26. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Liu B, Jin M, Ni Q, Liang X, Ma
X, Yao K, Li Q and Chen K: Genetic polymorphisms of transforming
growth factor-beta1 and its receptors and colorectal cancer
susceptibility: a population-based case-control study in China.
Cancer Lett. 275:102–108. 2009. View Article : Google Scholar
|
|
12
|
Dunning AM, Ellis PD, McBride S, et al: A
transforming growth factorbeta1 signal peptide variant increases
secretion in vitro and is associated with increased incidence of
invasive breast cancer. Cancer Res. 63:2610–2615. 2003.
|
|
13
|
Onitilo AA, Engel JM, Greenlee RT and
Mukesh BN: Breast cancer subtypes based on ER/PR and Her2
expression: comparison of clinicopathologic features and survival.
Clin Med Res. 7:4–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaklamani VG, Baddi L, Liu J, et al:
Combined genetic assessment of transforming growth factor-beta
signaling pathway variants may predict breast cancer risk. Cancer
Res. 65:3454–3461. 2005.PubMed/NCBI
|
|
15
|
Paiva CE, Drigo SA, Rosa FE, Moraes Neto
FA, Caldeira JR, Soares FA, Domingues MA and Rogatto SR: Absence of
transforming growth factor-beta type II receptor is associated with
poorer prognosis in HER2-negative breast tumours. Ann Oncol.
21:734–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banerjee SK, Makdisi WF, Weston AP,
Mitchell SM and Campbell DR: Microwave-based DNA extraction from
paraffin-embedded tissue for PCR amplification. Biotechniques.
18:768–770. 772–763. 1995.PubMed/NCBI
|
|
17
|
Sato Y, Sugie R, Tsuchiya B, Kameya T,
Natori M and Mukai K: Comparison of the DNA extraction methods for
polymerase chain reaction amplification from formalin-fixed and
paraffin-embedded tissues. Diagn Mol Pathol. 10:265–271. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi X, Zhang F, Yang X, Fan L, Zhang Y,
Chen L, Zhou Y, Chen X, Zhong L and Jiang J: Transforming growth
factor-beta1 polymorphisms and breast cancer risk: a meta-analysis
based on 27 case-control studies. Breast Cancer Res Treat.
122:273–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hishida A, Iwata H, Hamajima N, Matsuo K,
Mizutani M, Iwase T, Miura S, Emi N, Hirose K and Tajima K:
Transforming growth factor B1 T29C polymorphism and breast cancer
risk in Japanese women. Breast Cancer. 10:63–69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cox DG, Penney K, Guo Q, Hankinson SE and
Hunter DJ: TGFB1 and TGFBR1 polymorphisms and breast cancer risk in
the Nurses’ Health Study. BMC Cancer. 7:1752007.PubMed/NCBI
|
|
21
|
Jin Q, Hemminki K, Grzybowska E, Klaes R,
Soderberg M, Zientek H, Rogozinska-Szczepka J, Utracka-Hutka B,
Pamula J, Pekala W and Forsti A: Polymorphisms and haplotype
structures in genes for transforming growth factor beta1 and its
receptors in familial and unselected breast cancers. Int J Cancer.
112:94–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jin G, Wang L, Chen W, Hu Z, Zhou Y, Tan
Y, Wang J, Hua Z, Ding W, Shen J, Zhang Z, Wang X, Xu Y and Shen H:
Variant alleles of TGFB1 and TGFBR2 are associated with a decreased
risk of gastric cancer in a Chinese population. Int J Cancer.
120:1330–1335. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan
Y, Wang J, Hua Z, Ding W, Wang L, Chen W, Shen J, Wang X, Xu Y and
Shen H: TGFB1 and TGFBR2 functional polymorphisms and risk of
esophageal squamous cell carcinoma: a case-control analysis in a
Chinese population. J Cancer Res Clin Oncol. 134:345–351. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Knabbe C, Lippman ME, Wakefield LM,
Flanders KC, Kasid A, Derynck R and Dickson RB: Evidence that
transforming growth factor-beta is a hormonally regulated negative
growth factor in human breast cancer cells. Cell. 48:417–428. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wrana JL, Attisano L, Wieser R, Ventura F
and Massague J: Mechanism of activation of the TGF-beta receptor.
Nature. 370:341–347. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Buck M, von der Fecht J and Knabbe C:
Antiestrogenic regulation of transforming growth factor beta
receptors I and II in human breast cancer cells. Ann NY Acad Sci.
963:140–143. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Arteaga CL, Tandon AK, von Hoff DD and
Osborne CK: Transforming growth factor beta: potential autocrine
growth inhibitor of estrogen receptor-negative human breast cancer
cells. Cancer Res. 48:3898–3904. 1988.
|
|
28
|
Kalkhoven E, Roelen BA, de Winter JP,
Mummery CL, van den Eijnden-van Raaij AJ, van der Saag PT and van
der Burg B: Resistance to transforming growth factor beta and
activin due to reduced receptor expression in human breast tumor
cell lines. Cell Growth Differ. 6:1151–1161. 1995.PubMed/NCBI
|
